Ramaswamy Vivek
Insider CIK 1635075 · ABUS Director, 10% owner · ROIV Director, 10% owner · AXON Principal Executive Officer, Director, 10% owner · ASST 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-15 | 2025-12-15 | 832,453 | — | $0 | 22,150,227 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-15 | 2025-12-15 | 353,745 | $22.05 | $7.80M | 34,132,463 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-15 | 2025-12-15 | 832,453 | $12.68 | $10.56M | 34,486,208 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-15 | 2025-12-15 | 478,708 | $22.05 | $10.56M | 33,653,755 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-12 | 2025-12-15 | 4,672,724 | — | $0 | 22,982,680 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-12 | 2025-12-15 | 1,975,858 | $21.96 | $43.39M | 36,350,621 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-12 | 2025-12-15 | 2,696,866 | $21.96 | $59.22M | 33,653,755 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-12 | 2025-12-15 | 4,672,724 | $12.68 | $59.25M | 38,326,479 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-11 | 2025-12-15 | 1,869,691 | — | $0 | 27,655,404 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-11 | 2025-12-15 | 1,095,550 | $21.64 | $23.71M | 33,653,755 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-11 | 2025-12-15 | 774,142 | $21.64 | $16.75M | 34,749,305 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-11 | 2025-12-15 | 1,869,691 | $12.68 | $23.71M | 35,523,447 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-17 | 2025-11-17 | 539,650 | $20.51 | $11.07M | 33,653,756 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-14 | 2025-11-17 | 1,027,670 | $20.33 | $20.89M | 34,193,406 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-13 | 2025-11-17 | 287,283 | $20.81 | $5.98M | 35,221,076 | SEC↗ |
| ASST Strive, Inc. | P Buy | 2025-11-05 | 2025-11-07 | 15,625 | $80.00 | $1.25M | 15,625 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-09-05 | 2025-09-05 | 385,816 | $12.96 | $5.00M | 35,508,359 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-09-04 | 2025-09-05 | 194,933 | $12.92 | $2.52M | 35,894,175 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-09-03 | 2025-09-05 | 1,195,000 | $12.50 | $14.94M | 36,089,108 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-06-20 | 2025-06-23 | 577,007 | $11.46 | $6.61M | 37,284,108 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-06-18 | 2025-06-23 | 565,266 | $11.45 | $6.47M | 37,861,115 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-06-06 | 2025-06-06 | 200,800 | $11.19 | $2.25M | 38,426,381 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-06-04 | 2025-06-06 | 547,430 | $11.34 | $6.21M | 38,627,181 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-05-07 | 2025-05-08 | 625,000 | $11.18 | $6.99M | 39,174,611 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-05-06 | 2025-05-08 | 273,959 | $11.47 | $3.14M | 39,799,611 | SEC↗ |
| ROIV Roivant Sciences Ltd. | G Gift | 2025-01-23 | 2025-01-27 | 13,357,857 | — | $0 | 40,073,570 | SEC↗ |
| ROIV Roivant Sciences Ltd. | G Gift | 2025-01-23 | 2025-01-27 | 13,357,857 | — | $0 | 13,357,857 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-01-02 | 2024-01-03 | 3,000,000 | $11.05 | $33.15M | 51,929,426 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-12-27 | 2023-12-29 | 611,393 | $6.40 | $3.91M | 7,132,921 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-12-27 | 2023-12-29 | 251,538 | $11.50 | $2.89M | 11,570,769 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-12-27 | 2023-12-29 | 275,227 | — | $0 | 55,063,337 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2023-12-27 | 2023-12-29 | 133,911 | $11.58 | $1.55M | 54,929,426 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-09-28 | 2023-09-29 | 61,947 | $12.67 | $784.9K | 54,788,110 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 251,539 | $11.50 | $2.89M | 11,822,307 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 203,798 | $6.40 | $1.30M | 7,744,314 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-09-27 | 2023-09-29 | 119,534 | — | $0 | 54,850,057 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-08-28 | 2023-08-29 | 47,692 | $11.25 | $536.5K | 54,730,523 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-08-27 | 2023-08-29 | 203,798 | $6.40 | $1.30M | 7,948,112 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-08-27 | 2023-08-29 | 86,714 | — | $0 | 54,778,215 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-07-31 | 2023-08-01 | 76,023 | $11.43 | $868.9K | 54,691,501 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-07-27 | 2023-08-01 | 407,595 | $6.40 | $2.61M | 8,151,910 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-07-27 | 2023-08-01 | 166,057 | — | $0 | 54,767,524 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-05-31 | 2023-05-31 | 189,947 | $9.09 | $1.73M | 54,601,467 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-05-27 | 2023-05-31 | 1,222,787 | $6.40 | $7.83M | 8,559,505 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-05-27 | 2023-05-31 | 382,203 | — | $0 | 54,791,414 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-02-22 | 2023-02-22 | 4,000,000 | $7.95 | $31.80M | 54,409,211 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-06-19 | 2018-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2016-06-03 | 2016-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2016-04-29 | 2016-05-03 | 357,000 | — | $0 | 357,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2015-08-12 | 2015-08-14 | 7,500 | — | $0 | 7,500 | SEC↗ |